Cofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain Spinout
Culmination Bio's 4.5 million biospecimens and longitudinal omics and clinical data may help Cofactor rapidly advance the OncoPrism assay into multiple cancer types.
Freenome, Siemens Healthineers Partner to ID Blood-Based Breast Cancer Biomarkers
The companies aim to use multiomic and other types of data to identify blood-based biomarkers that can help in the early diagnosis of breast cancer.
Caris Life Sciences Raises $830M to Support Precision Medicine Platform, Liquid Biopsy Development
The funds will help support Caris' ongoing commercial efforts in comprehensive cancer genomics as it makes new forays into liquid biopsy for multi-cancer early detection.
WuXi Diagnostics Closes $150M Series B Financing Round
The Chinese company said it would use some of the funding to advance its integrated diagnostics research and development pipeline.